Matthew Thompson

Matthew Thompson

Director/Board Member at VIVOS THERAPEUTICS, INC.

Net worth: - $ as of 2026-05-30

64 year
Health Technology
Consumer Services
Miscellaneous

Profile

Matthew Thompson is the founder of British Society of Endovascular Therapy Ltd., founded in 2004.
Current jobs include Chief Executive Officer & Director at TriVascular, Inc., Chief Executive Officer & Director at Life Seal Vascular, Inc. starting in 2025, Chief Executive Officer at Exstent Ltd. starting in 2025, Independent Director at Vivos Therapeutics, Inc. since 2020, President of The Vascular Society since 2018, and Professor at Stanford School of Medicine since 2017.
Former jobs include Director, Chief Medical Officer & Executive VP at Endologix LLC from 2016 to 2025, Professor-Vascular Surgery at St. George's University of London from 2002 to 2016, and Professor at St Georges Vascular Institute from 2002 to 2016.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2025-09-07 0 ( -.--% ) - $ 2026-05-30

Matthew Thompson active positions

CompaniesPositionStart
VIVOS THERAPEUTICS, INC. Director/Board Member 2020-05-31
President 2017-12-31
Corporate Officer/Principal 2016-12-31
Chief Executive Officer -
Chief Executive Officer 2025-11-10

Former positions of Matthew Thompson

CompaniesPositionEnd
ENDOLOGIX, INC. Chief Executive Officer 2025-01-06
Corporate Officer/Principal 2015-12-31
Corporate Officer/Principal 2015-12-31
British Society of Endovascular Therapy Ltd.
Founder -
See the detail of Matthew Thompson's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

25

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies9

Health Technology

Health Technology

Consumer Services

Health Technology

Miscellaneous

Health Technology

British Society of Endovascular Therapy Ltd.

Consumer Services

Consumer Services

  1. Stock Market
  2. Insiders
  3. Matthew Thompson
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!